Streptokinase biosimilar (Biocon)

链激酶生物类似药 (Biocon)

Report date: 2022/01/22 15:19:11

Base Information

Drug NameStreptokinase biosimilar (Biocon)

Drug Alias Name溶栓酶生物仿制药 (Biocon)Recombinant streptokinase (Biocon)链激酶生物仿制药 (Biocon)Myokinase

ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzymeBiologics > Biosimilar

Mechanisms of ActionPlasminogen stimulants

TargetsPlasminogen

Therapy Area/IndicationsVenous ThrombosisMyocardial InfarctionPulmonary Embolism

Global Approved IndicationsVenous ThrombosisMyocardial InfarctionPulmonary Embolism

Approved Indications in ChinaN/A

Original Approved Country/TerritoryIndia

Original Approved Date2008/01/01

Country/TerritoryIndia

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesBiocon Ltd

China Registration ClassN/A

Develop Information

Active CompaniesBiocon Ltd

Inactive CompaniesN/A

Active IndicationsVenous ThrombosisMyocardial InfarctionPulmonary Embolism

Inactive IndicationsN/A

Other Information

ATC CodeB01AD01